TREATMENT FOR SARS-COV-2 WITH VIR-7831 MONOCLONAL ANTIBODIES IN ADULT OUTPATIENTS
The VIR-7831 study is testing an infusion of VIR-7831, an antibody that targets SARS-CoV-2, the virus that causes COVID-19, to determine whether it can decrease the rate of progression to severe disease in patients with mild/moderate COVID-19. This study is being conducted at Fred Hutch’s COVID-19...